Timeline Nutrition, founded in 2007 as Amazentis, is a Swiss longevity brand that focuses on developing science-based products to target aging. Their mission is to extend healthspan through clinically proven science, not hype. At the core of their products is Mitopure, a proprietary Urolithin A, which has been shown to improve mitochondrial function. The company was spun out of the Swiss Federal Institute of Technology Lausanne (EPFL). In January 2026, Timeline launched its first national campaign, "It's About Time", to promote longevity.
Timeline Nutrition's products include softgels, powder, gummies, and skincare, all powered by Mitopure. These products are designed to support cellular health, muscle strength, and overall energy. The company has invested over $50 million in research and clinical development and has over 80 global patents centered around Mitopure. Timeline is recognized as a leader in clinically proven longevity interventions and was named a Top 40 Global Finalist in the $101M XPRIZE Healthspan Competition in 2025. Stephan Gratziani was appointed CEO in May 2025, with Michael O. Johnson transitioning to Executive Chairman. In January 2024, Timeline Nutrition raised $66M in a Series D round co-led by Nestlé Health Science and L'Oréal's VC arm BOLD, to extend its anti-aging technology across new products and sectors, including food and beauty.
